Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Long-Term Investments (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Long-Term Investments for 16 consecutive years, with $396.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 23.75% to $396.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $396.0 million through Dec 2025, up 23.75% year-over-year, with the annual reading at $396.0 million for FY2025, 23.75% up from the prior year.
  • Long-Term Investments for Q4 2025 was $396.0 million at Bristol Myers Squibb, down from $406.0 million in the prior quarter.
  • The five-year high for Long-Term Investments was $406.0 million in Q3 2025, with the low at $46.0 million in Q3 2021.
  • Average Long-Term Investments over 4 years is $308.4 million, with a median of $345.0 million recorded in 2025.
  • The sharpest move saw Long-Term Investments crashed 90.71% in 2021, then rose 25.31% in 2025.
  • Over 4 years, Long-Term Investments stood at $46.0 million in 2021, then skyrocketed by 691.3% to $364.0 million in 2023, then fell by 12.09% to $320.0 million in 2024, then increased by 23.75% to $396.0 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $396.0 million, $406.0 million, and $346.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.